Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1973 1
1974 4
1975 2
1976 2
1977 6
1978 2
1979 4
1980 10
1981 4
1982 13
1983 5
1984 9
1985 6
1986 4
1987 8
1988 4
1989 6
1990 8
1991 6
1992 18
1993 18
1994 7
1995 8
1996 14
1997 14
1998 11
1999 15
2000 25
2001 13
2002 9
2003 14
2004 10
2005 13
2006 16
2007 15
2008 11
2009 16
2010 14
2011 16
2012 21
2013 14
2014 16
2015 13
2016 12
2017 9
2018 7
2019 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

451 results
Results by year
Filters applied: . Clear all
Page 1
Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer.
Vergote I, Tropé CG, Amant F, Kristensen GB, Ehlen T, Johnson N, Verheijen RH, van der Burg ME, Lacave AJ, Panici PB, Kenter GG, Casado A, Mendiola C, Coens C, Verleye L, Stuart GC, Pecorelli S, Reed NS; European Organization for Research and Treatment of Cancer-Gynaecological Cancer Group; NCIC Clinical Trials Group. Vergote I, et al. Among authors: trope cg. N Engl J Med. 2010 Sep 2;363(10):943-53. doi: 10.1056/NEJMoa0908806. N Engl J Med. 2010. PMID: 20818904 Free article. Clinical Trial.
Advanced Ovarian Cancer: Primary or Interval Debulking? Five Categories of Patients in View of the Results of Randomized Trials and Tumor Biology: Primary Debulking Surgery and Interval Debulking Surgery for Advanced Ovarian Cancer.
Makar AP, Tropé CG, Tummers P, Denys H, Vandecasteele K. Makar AP, et al. Among authors: trope cg. Oncologist. 2016 Jun;21(6):745-54. doi: 10.1634/theoncologist.2015-0239. Epub 2016 Mar 23. Oncologist. 2016. PMID: 27009938 Free PMC article. Review.
Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial.
Parmar MK, Ledermann JA, Colombo N, du Bois A, Delaloye JF, Kristensen GB, Wheeler S, Swart AM, Qian W, Torri V, Floriani I, Jayson G, Lamont A, Tropé C; ICON and AGO Collaborators. Parmar MK, et al. Among authors: trope c. Lancet. 2003 Jun 21;361(9375):2099-106. doi: 10.1016/s0140-6736(03)13718-x. Lancet. 2003. PMID: 12826431 Clinical Trial.
MicroRNAs in Ovarian Cancer.
Katz B, Tropé CG, Reich R, Davidson B. Katz B, et al. Among authors: trope cg. Hum Pathol. 2015 Sep;46(9):1245-56. doi: 10.1016/j.humpath.2015.06.013. Epub 2015 Jun 30. Hum Pathol. 2015. PMID: 26216350 Review.
Borderline ovarian tumours.
Tropé CG, Kaern J, Davidson B. Tropé CG, et al. Best Pract Res Clin Obstet Gynaecol. 2012 Jun;26(3):325-36. doi: 10.1016/j.bpobgyn.2011.12.006. Epub 2012 Feb 7. Best Pract Res Clin Obstet Gynaecol. 2012. PMID: 22321906 Review.
Epithelial ovarian carcinoma.
Kristensen GB, Tropé C. Kristensen GB, et al. Among authors: trope c. Lancet. 1997 Jan 11;349(9045):113-7. doi: 10.1016/S0140-6736(96)06071-0. Lancet. 1997. PMID: 8996432 Review. No abstract available.
The role of the tumor stroma in ovarian cancer.
Davidson B, Trope CG, Reich R. Davidson B, et al. Among authors: trope cg. Front Oncol. 2014 May 13;4:104. doi: 10.3389/fonc.2014.00104. eCollection 2014. Front Oncol. 2014. PMID: 24860785 Free PMC article. Review.
[Endometrial hyperplasia--diagnosis and treatment].
Tropé CG, Marth C, Scheistrøen M, Abeler VM. Tropé CG, et al. Tidsskr Nor Laegeforen. 1999 May 30;119(14):2030-4. Tidsskr Nor Laegeforen. 1999. PMID: 10394278 Review. Norwegian.
451 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page